MacroGenics
MGNX
#8247
Rank
A$0.38 B
Marketcap
A$6.11
Share price
-3.42%
Change (1 day)
165.60%
Change (1 year)

EPS for MacroGenics (MGNX)

EPS in 2025 (TTM): A-$0.20

According to MacroGenics's latest financial reports the company's current EPS (TTM) is A-$0.06978. In 2024 the company made an earnings per share (EPS) of A-$1.49 a decrease over its 2023 EPS that were of A-$0.21.

EPS history for MacroGenics from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)A-$0.20-86.74%
2024A-$1.49613.33%
2023A-$0.21-92.31%
2022A-$2.72-42.14%
2021A-$4.7036.44%
2020A-$3.45-21.84%
2019A-$4.41-24.58%
2018A-$5.85675.93%
2017A-$0.75-68.05%
2016A-$2.36168.25%
2015A-$0.88-55%
2014A-$1.953400%
2013A-$0.05583-108.68%
2012A$0.6424.49%
2011A$0.52

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
A$1.83-2,720.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$39.39-56,550.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$20.21-29,060.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
A$9.56-13,800.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$4.96-7,214.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$4.97-7,220.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
A-$2.47 3,440.00%๐Ÿ‡บ๐Ÿ‡ธ USA